Search results for "Ion transport"

showing 10 items of 162 documents

Extensive molecular analysis of patients bearing CFTR-related disorders.

2012

Cystic fibrosis transmembrane conductance regulator (CFTR)–related disorders (CFTR-RDs) may present with pancreatic sufficiency, normal sweat test results, and better outcome. The detection rate of mutations is lower in CFTR-RD than in classic CF: mutations may be located in genes encoding proteins that interact with CFTR or support channel activity. We tested the whole CFTR coding regions in 99 CFTR-RD patients, looking for gene mutations in solute carrier (SLC) 26A and in epithelial Na channel (ENaC) in 33 patients who had unidentified mutations. CFTR analysis revealed 28 mutations, some of which are rare. Of these mutations, RT-PCR demonstrated that the novel 1525-1delG impairs exon 10 s…

Epithelial sodium channelcongenital hereditary and neonatal diseases and abnormalitiesCystic fibrosis CFTR SLC26A SCNNCystic FibrosisAnion Transport ProteinsDNA Mutational Analysismolecular analysiCystic Fibrosis Transmembrane Conductance RegulatorGene mutationPathology and Forensic Medicinecongenital bilateral absence of vasa deferentesExonGene Frequencydisseminated bronchiectasiscongenital bilateral absence of vasa deferenteHumansTrypsinmolecular analysisEpithelial Sodium ChannelsGeneCells CulturedGenetic Association StudiesGeneticsbiologydisseminated bronchiectasiEpithelial Cellsrespiratory systemrecurrent pancreatitidigestive system diseasesCystic fibrosis transmembrane conductance regulatorrespiratory tract diseasesSolute carrier familyCFTR related disordersTrypsin Inhibitor Kazal PancreaticCase-Control StudiesRNA splicingMutationbiology.proteinMolecular MedicineCFTR related disorderSLC26 familyCarrier ProteinsNa channel ENaCMinigenerecurrent pancreatitis
researchProduct

Involvement of carboxyl groups in chloride transport and reversible DIDS binding to band 3 protein in human erythrocytes

2011

AbstractNoncovalent DIDS binding to Band 3 (AE1) protein in human erythrocyte membranes, modified by non-penetrating, water soluble 1-ethyl-3-(4-azonia-4,4-dimethylpentyl)-carbodiimide iodide (EAC), was studied at 0°C in the presence of 165 mM KCl. Under experimental conditions applied up to (48 ± 5) % of irreversible chloride self-exchange inhibition was observed. The apparent dissociation constant, KD, for “DIDS-Band 3” complex, determined from the chloride transport experiments, was (34 ± 3) nM and (80 ± 12) nM for control and EAC-treated resealed ghosts, respectively. The inhibition constant, Ki, for DIDS was (35 ± 6) nM and (60 ± 8) nM in control and EAC-treated ghosts, respectively. T…

ErythrocytesIodideDissociation constant44'-Diisothiocyanostilbene-22'-Disulfonic AcidTritiumBiochemistryChloridechemistry.chemical_compoundCarbodiimideChloridesAnion Exchange Protein 1 ErythrocytemedicineHumansBinding siteErythrocyte membraneMolecular BiologyBand 3Ion transporterchemistry.chemical_classificationStilbenedisulfonateBinding SitesIon TransportbiologyCooperative bindingCell BiologyDissociation constantBand 3CrystallographyCarbodiimidesKineticsBiochemistrychemistryDIDSbiology.proteinmedicine.drugResearch ArticleProtein BindingCellular & Molecular Biology Letters
researchProduct

Production of neutron deficient rare isotope beams at IGISOL; on-line and off-line studies

2004

This article reports on recent on-line yield measurements employing the light-ion and heavy-ion reaction-based ion guide systems and new results on a-recoil ion transport properties in ion guides with and without electric fields. In addition, the presently used ion guide designs for fusion evaporation reactions are introduced. The present study investigated different schemes for ion extraction from the gas cell. The addition of an extra ring electrode between the traditional skimmer electrode and the exit hole led to transmission independent of the primary beam intensity as opposed to strong intensity dependence observed earlier with the plain skimmer only. Furthermore, the mass resolving p…

FUSION-EVAPORATION REACTIONSISOMERNuclear and High Energy PhysicsEFFICIENCYIon beamChemistryHF-171Buffer gasion guideElectronIon gunSTATEon-line isotope separationIonION-GUIDE TECHNIQUEIon beam depositionPhysics::Plasma PhysicsNeutronSEPARATOR ONLINEAtomic physicsLASER SPECTROSCOPYSPIGInstrumentationIon transporterNuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
researchProduct

The inhibitory neural circuitry as target of antiepileptic drugs.

2001

Impairments and defects in the inhibitory neurotransmission in the CNS can contribute to various seizure disorders, i.e., gamma-aminobutyric acid (GABA) and glycine as the main inhibitory neurotransmitters in the brain play a crucial role in some forms of epilepsy. Recent advances in deciphering the molecular basis of the GABAergic and glycinergic systems has been achieved by means of cloning techniques and gene targeting strategies in animals, contributing to the understanding of drug action. As well, several anticonvulsive substances emerged which target key molecules of the inhibitory systems. Employment of recombinant expression systems, including, but not restricted to the inhibitory c…

GABA Plasma Membrane Transport ProteinsGABA Plasma Membrane Transport ProteinsOrganic Anion TransportersDrug actionPharmacologyNeurotransmissionBiologyInhibitory postsynaptic potentialBiochemistrySynaptic TransmissionGABA AntagonistsEpilepsyDrug DiscoverymedicineAnimalsHumansGlycine receptorgamma-Aminobutyric AcidPharmacologyEpilepsyOrganic ChemistryMembrane ProteinsMembrane Transport Proteinsmedicine.diseaseReceptors GABA-AMechanism of actionReceptors GABA-BMolecular MedicineGABAergicAnticonvulsantsmedicine.symptomCarrier ProteinsCurrent medicinal chemistry
researchProduct

Effects of GABA-transporter (GAT) inhibitors on rat behaviour in open-field and elevated plus-maze.

1999

The behavioural consequences of inhibition of gamma-aminobutyric acid (GABA) uptake were studied. Two GABA uptake inhibitors, tiagabine and SKF 89976-A, were administered to rats, and behaviour was analysed 30 min later in a standard open field, an enriched open field, and an elevated plus-maze. Eight groups of animals received either saline (0.9%), tiagabine, or SKF 89976-A. At a dose of 18.5 mg/kg, tiagabine, an established antiseizure drug, impaired motor coordination, enhanced exploratory activity and reduced anxiety related behaviour. SKF 89976-A exhibited minimal effects over the dose range tested. These results indicate that inhibition of GABA uptake might be a pharmacological strate…

GABA Plasma Membrane Transport ProteinsMaleElevated plus mazeGABA Plasma Membrane Transport ProteinsTiagabineGABA AgentsNipecotic AcidsOrganic Anion TransportersPharmacologyAnxietyEnvironmentMotor Activitygamma-Aminobutyric acidOpen fieldmedicineGABA transporterAnimalsTiagabineGABA Agonistsgamma-Aminobutyric AcidPharmacologybiologyBehavior AnimalDose-Response Relationship DrugChemistryMembrane ProteinsMembrane Transport ProteinsRatsPsychiatry and Mental healthGABA Agentsnervous systembiology.proteinExploratory BehaviorGABA Uptake InhibitorsAnticonvulsantsCarrier Proteinsmedicine.drugBehavioural pharmacology
researchProduct

Chloride, carboxylate and carbonate transport by ortho-phenylenediamine-based bisureas

2013

Highly potent but structurally simple transmembrane anion transporters are reported that function at receptor to lipid ratios as low as 1 : 1 000 000. The compounds, based on the simple ortho-phenylenediamine-based bisurea scaffold, have been studied for their ability to facilitate chloride/nitrate and chloride/bicarbonate antiport, and HCl symport processes using a combination of ion selective electrode and fluorescence techniques. In addition, the transmembrane transport of dicarboxylate anions (maleate and fumarate) by the compounds was examined. Molecular dynamics simulations showed that these compounds permeate the membrane more easily than other promising receptors corroborating the e…

GLUTAMATE TRANSPORTERSSTEROID-BASED RECEPTORSAntiporterBicarbonateMOLECULAR RECOGNITIONISOMERIC DICARBOXYLATE ANIONS010402 general chemistry01 natural sciencesChlorideIon selective electrodechemistry.chemical_compoundmedicineOrganic chemistryCarboxylate010405 organic chemistryGeneral ChemistryIN-VITROMembrane transportSELECTIVE DISCRIMINATIONTRANSMEMBRANE ANION TRANSPORTERSCombinatorial chemistryMEMBRANE TRANSPORTERS0104 chemical sciences3. Good healthMembranechemistryCONFORMATIONAL CONTROLINTRACELLULAR PHEffluxmedicine.drug
researchProduct

Genomic Structure and in Vivo Expression of the Human Organic Anion Transporter 1 (hOAT1) Gene

2000

The human organic anion transporter 1 (hOAT1) plays a key role in the secretion of an array of potentially toxic organic anions including many clinically important drugs. Here we report on the genomic cloning of hOAT1. A human genomic library was used for screening of a PAC (P1 artificial chromosome) clone applying PCR techniques. Sequencing of several restriction subclones and of a PCR-generated clone revealed that the hOAT1 gene spans 8.2 kb and is composed of 10 exons divided by 9 introns. RT-PCR studies in a human kidney specimen led to the detection of two new splice variants, hOAT1-3 and hOAT1-4, showing a 132-bp in-frame deletion. Using fluorescence in situ hybridization (FISH) we ma…

Gene isoformAnion Transport ProteinsMolecular Sequence DataBiophysicsBiologyBiochemistryExonmedicineHumansGenomic libraryPromoter Regions GeneticMolecular BiologyGeneIn Situ Hybridization FluorescenceDNA PrimersGeneticsBase Sequencemedicine.diagnostic_testReverse Transcriptase Polymerase Chain ReactionChromosomes Human Pair 11Chromosome MappingPromoterDNAExonsCell BiologyTCF4Molecular biologyIntronsDNA binding siteCarrier ProteinsFluorescence in situ hybridizationBiochemical and Biophysical Research Communications
researchProduct

The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

1998

The amino acid gamma-aminobutyric-acid (GABA) prevails in the CNS as an inhibitory neurotransmitter that mediates most of its effects through fast GABA-gated Cl(-)-channels (GABAAR). Molecular biology uncovered the complex subunit architecture of this receptor channel, in which a pentameric assembly derived from five of at least 17 mammalian subunits, grouped in the six classes alpha, beta, gamma, delta, sigma and epsilon, permits a vast number of putative receptor isoforms. The subunit composition of a particular receptor determines the specific effects of allosterical modulators of the GABAARs like benzodiazepines (BZs), barbiturates, steroids, some convulsants, polyvalent cations, and et…

Gene isoformMacromolecular SubstancesProtein ConformationProtein subunitNeuroscience (miscellaneous)LoreclezoleConvulsantsBiologyInhibitory postsynaptic potentialGABAA-rho receptorSubstrate SpecificityGABA AntagonistsCellular and Molecular NeuroscienceBenzodiazepinesMiceChloride ChannelsmedicineAnimalsHumansProtein IsoformsReceptorGABA Agonistsgamma-Aminobutyric AcidAnestheticsMice KnockoutBinding SitesIon TransportGABAA receptorReceptors GABA-ARecombinant ProteinsRatsElectrophysiologyNeurologyBiochemistryBarbituratesSteroidsHeterologous expressionIon Channel Gatingmedicine.drugMolecular neurobiology
researchProduct

Molecular Characterization of a Chromosomal Rearrangement Involved in the Adaptive Evolution of Yeast Strains

2002

Wine yeast strains show a high level of chromosome length polymorphism. This polymorphism is mainly generated by illegitimate recombination mediated by Ty transposons or subtelomeric repeated sequences. We have found, however, that the SSU1-R allele, which confers sulfite resistance to yeast cells, is the product of a reciprocal translocation between chromosomes VIII and XVI due to unequal crossing-over mediated by microhomology between very short sequences on the 5' upstream regions of the SSU1 and ECM34 genes. We also show that this translocation is only present in wine yeast strains, suggesting that the use for millennia of sulfite as a preservative in wine production could have favored …

Genetic MarkersSaccharomyces cerevisiae ProteinsLetterChromosomal rearrangementsAnion Transport ProteinsGenes FungalMolecular Sequence DataSaccharomyces cerevisiaeSaccharomyces cerevisiaeChromosomal rearrangementSaccharomycesGenètica molecularTranslocation GeneticEvolution MolecularSaccharomycesGene FrequencySpecies SpecificityGeneticsVinificationDNA FungalGeneGenetics (clinical)Wine yeastsGene RearrangementRecombination GeneticGeneticsBase SequencebiologyGene rearrangementbiology.organism_classificationYeastYeast in winemakingChromosomes FungalGenome FungalPloidyGenome Research
researchProduct

Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

2013

Interpatient variability in drug response can be widely explained by genetically determined differences in metabolizing enzymes, drug transporters, and drug targets, leading to different pharmacokinetic and/or pharmacodynamic behaviors of drugs. Genetic variations affect or do not affect drug responses depending on their influence on protein activity and the relevance of such proteins in the pathway of the drug. Also, the frequency of such genetic variations differs among populations, so the clinical relevance of a specific variation is not the same in all of them. In this study, a panel of 33 single nucleotide polymorphisms in 14 different genes (ABCB1, ABCC2, ABCG2, CYP2B6, CYP2C19, CYP2C…

GenotypeCYP2B6Nod2 Signaling Adaptor ProteinOrganic Anion TransportersSingle-nucleotide polymorphismCYP2C19PharmacologyPolymorphism Single NucleotideWhite PeopleCytochrome P-450 Enzyme SystemGene FrequencyGenetic variationGenotypeHumansPharmacology (medical)ATP Binding Cassette Transporter Subfamily B Member 1GlucuronosyltransferaseAllele frequencyCYP2C9Methylenetetrahydrofolate Reductase (NADPH2)PharmacologyGeneticsbiologyMethyltransferasesMultidrug Resistance-Associated Protein 2Tissue DonorsTransplant RecipientsSpainInactivation MetabolicUDP-Glucuronosyltransferase 1A9biology.proteinSLCO1B1Immunosuppressive AgentsTherapeutic Drug Monitoring
researchProduct